Hefei Lifeon Pharmaceutical Co., Ltd.
SZSE:003020.SZ
25.2 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 502.929 | 642.58 | 654.254 | 766.586 | 223.244 | 154.457 | 76.43 | 75.773 | 57.254 | 40.23 | 49.694 |
| Short Term Investments
| 61.52 | 0.115 | 0.133 | 0 | 0 | 0 | -5.293 | -5.743 | -7.1 | -1.083 | -0.494 |
| Cash and Short Term Investments
| 564.449 | 642.695 | 654.386 | 766.586 | 223.244 | 154.457 | 76.43 | 75.773 | 57.254 | 40.23 | 49.694 |
| Net Receivables
| 259.239 | 321.02 | 318.369 | 285.283 | 265.024 | 229.601 | 181.284 | 109.647 | 86.544 | 108.111 | 9.433 |
| Inventory
| 242.914 | 361.765 | 188.857 | 193.8 | 179.167 | 168.827 | 155.948 | 154.909 | 145.9 | 116.72 | 73.279 |
| Other Current Assets
| 84.544 | 127.067 | 58.035 | 44.382 | 27.393 | 52.656 | 25.984 | 34.67 | 23.499 | 42.209 | 123.592 |
| Total Current Assets
| 1,151.147 | 1,452.547 | 1,219.648 | 1,291.961 | 694.829 | 605.542 | 439.646 | 374.998 | 313.197 | 307.27 | 255.999 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 896.216 | 538.117 | 299.03 | 199.033 | 146.097 | 129.877 | 118.392 | 119.424 | 122.511 | 105.745 | 89.115 |
| Goodwill
| 74.441 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 115.369 | 84.768 | 90.244 | 31.42 | 31.51 | 21.927 | 21.255 | 21.867 | 23.235 | 23.088 | 7.178 |
| Goodwill and Intangible Assets
| 189.81 | 84.768 | 90.244 | 31.42 | 31.51 | 21.927 | 21.255 | 21.867 | 23.235 | 23.088 | 7.178 |
| Long Term Investments
| 206.008 | 14.283 | 20.575 | 4.409 | 4.423 | 4.808 | 23.293 | 23.743 | 7.75 | 1.733 | 1.144 |
| Tax Assets
| 16.129 | 8.938 | 5.859 | 3.373 | 4.345 | 3.621 | 3.404 | 2.964 | 3.22 | 2.932 | 1.649 |
| Other Non-Current Assets
| 24.37 | 23.102 | 39.09 | 5.823 | 8.61 | 5.233 | 6.862 | 4.806 | 5.727 | 5.456 | 3.55 |
| Total Non-Current Assets
| 1,332.533 | 669.209 | 454.797 | 244.058 | 194.985 | 165.465 | 173.206 | 172.804 | 162.444 | 138.954 | 102.636 |
| Total Assets
| 2,483.68 | 2,121.756 | 1,674.445 | 1,536.02 | 889.813 | 771.007 | 612.852 | 547.802 | 475.641 | 446.224 | 358.635 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 301.251 | 460.655 | 242.929 | 280.278 | 200.349 | 173.771 | 127.799 | 152.138 | 136.868 | 126.466 | 124.915 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 24.041 | 35 | 65 | 50 | 72 | 94 | 62 |
| Tax Payables
| 15.526 | 27.684 | 29.649 | 8.301 | 7.883 | 10.989 | 8.905 | 7.864 | 12.104 | 10.187 | 6.443 |
| Deferred Revenue
| 0 | 42.616 | 14.691 | 20.013 | 40.543 | 10.989 | 25.21 | 23.485 | 40.033 | 32.139 | 21.926 |
| Other Current Liabilities
| 225.953 | 134.289 | 55.476 | 53.769 | 49.146 | 32.055 | 4.56 | 26.64 | 32.655 | 36.228 | 22.308 |
| Total Current Liabilities
| 542.729 | 622.628 | 328.054 | 342.348 | 281.418 | 251.815 | 231.475 | 236.643 | 253.626 | 266.881 | 215.666 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 33.856 | 3.38 | 24.584 | 19.308 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 20.164 | 12.979 | 13.237 | 12.378 | 13.718 | 8.831 | 9.39 | 6.292 | 5.3 | 2.441 | 1.005 |
| Deferred Tax Liabilities Non-Current
| 13.432 | 1.387 | 0 | -19.308 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 1.16 | 17.897 | 0.37 | 18.397 | 4.66 | 10.273 | 6.773 | 6.481 | 0.022 | 0 |
| Total Non-Current Liabilities
| 67.452 | 18.907 | 42.48 | 19.678 | 18.397 | 13.491 | 19.663 | 13.066 | 6.481 | 2.464 | 1.005 |
| Total Liabilities
| 610.182 | 641.535 | 370.534 | 362.026 | 299.815 | 265.306 | 251.138 | 249.708 | 260.107 | 269.345 | 216.67 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 159.675 | 122.467 | 92.64 | 92.64 | 69.48 | 69.48 | 66 | 66 | 66 | 66 | 66 |
| Retained Earnings
| 912.969 | 766.493 | 636.647 | 511.105 | 414.995 | 330.777 | 267.814 | 209.859 | 132.246 | 95.477 | 62.308 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 71.889 | 52.47 | 48.095 | 36.88 | 105.444 | 27.899 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 612.882 | 527.888 | 522.154 | 522.154 | 68.644 | 105.444 | 0 | -0 | 20.878 | 17.024 | 13.069 |
| Total Shareholders Equity
| 1,685.526 | 1,480.221 | 1,303.911 | 1,173.993 | 589.998 | 505.701 | 361.713 | 298.094 | 219.124 | 178.501 | 141.377 |
| Total Equity
| 1,873.498 | 1,480.221 | 1,303.911 | 1,173.993 | 589.998 | 505.701 | 361.713 | 298.094 | 215.533 | 176.88 | 141.965 |
| Total Liabilities & Shareholders Equity
| 2,483.68 | 2,121.756 | 1,674.445 | 1,536.02 | 889.813 | 771.007 | 612.852 | 547.802 | 475.641 | 446.224 | 358.635 |